Premature Ovarian Failure (POF) Panel
Use
This test is designed for individuals who exhibit features associated with primary ovarian insufficiency or are suspected of having this condition. It is particularly relevant for females under the age of 40 who present with primary amenorrhea or a loss of menstrual function. Additionally, it is suitable for women who have elevated levels of follicle-stimulating hormone (FSH) and decreased estrogen levels. The test aims to identify genetic causes that contribute to premature ovarian failure, aiding in diagnosis and management.
Special Instructions
The test can be ordered using the standard test requisition form from PreventionGenetics. Both Exome and Genome platforms are available, and the analysis includes copy number variation (CNV) detection. For specimens collected in New York, specific state forms and approvals are needed. The test also offers options such as 'STAT Testing' which expedites the processing time.
Limitations
The test is limited to the genes included in the panel and the coverage provided by the Exome or Genome platforms used. It may not detect all genetic causes of premature ovarian failure, especially those not covered by the chosen testing platform. The performance of this test is based on validation by PreventionGenetics and has not been cleared or approved by the US Food and Drug Administration. As with any diagnostic test, potential for false negative or false positive results exists, and results should be interpreted in the context of clinical findings and family history.
New York Approved
Methodology
NGS (CGP)
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided